On August 27, 2026, Schroders PLC bought 428,600 shares of TIGERMED (03347) (H shares) at an average of HKD 40.2586 per share, involving about HKD 17.25 million.
Prior to the acquisition, Schroders PLC's long position in TIGERMED was 8.38 million shares, representing 6.8%; following the acquisition, the holding changed to 8.81 million shares, with the long position ratio rising to 7.15%.